Global Ophthalmic Biologics Market Growth 2026-2032
The global Ophthalmic Biologics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Ophthalmic Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Ophthalmic Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Ophthalmic Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Ophthalmic Biologics players cover Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Ophthalmic Biologics Industry Forecast? looks at past sales and reviews total world Ophthalmic Biologics sales in 2025, providing a comprehensive analysis by region and market sector of projected Ophthalmic Biologics sales for 2026 through 2032. With Ophthalmic Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Biologics industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ophthalmic Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Biologics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Biologics.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Ophthalmic Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Ophthalmic Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Ophthalmic Biologics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Ophthalmic Biologics players cover Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Ophthalmic Biologics Industry Forecast? looks at past sales and reviews total world Ophthalmic Biologics sales in 2025, providing a comprehensive analysis by region and market sector of projected Ophthalmic Biologics sales for 2026 through 2032. With Ophthalmic Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Biologics industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ophthalmic Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Biologics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Biologics.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Ranibizumab
- Bevacizumab
- Aflibercept
- Brolucizumab
- Faricimab
- Others
- Age-related Macular Degeneration Treatment
- Diabetic Retinopathy Treatment
- Inhibit Abnormal Angiogenesis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Novartis
- Bayer
- Genentech
- Apellis Pharmaceuticals, Inc.
- Coherus BioSciences Inc.
- Iveric Bio
- Regeneron
- Qilu Pharmaceutical Co.,Ltd.
- Chengdu Kanghong Pharmaceutical Group
- What is the 10-year outlook for the global Ophthalmic Biologics market?
- What factors are driving Ophthalmic Biologics market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Ophthalmic Biologics market opportunities vary by end market size?
- How does Ophthalmic Biologics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Biologics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ophthalmic Biologics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ophthalmic Biologics by Country/Region, 2021, 2025 & 2032
2.2 Ophthalmic Biologics Segment by Type
2.2.1 Ranibizumab
2.2.2 Bevacizumab
2.2.3 Aflibercept
2.2.4 Brolucizumab
2.2.5 Faricimab
2.2.6 Others
2.2.7 Ophthalmic Biologics Sales by Type
2.2.7.1 Global Ophthalmic Biologics Sales Market Share by Type (2021-2026)
2.2.7.2 Global Ophthalmic Biologics Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Ophthalmic Biologics Sale Price by Type (2021-2026)
2.3 Ophthalmic Biologics Segment by Application
2.3.1 Age-related Macular Degeneration Treatment
2.3.2 Diabetic Retinopathy Treatment
2.3.3 Inhibit Abnormal Angiogenesis
2.3.4 Ophthalmic Biologics Sales by Application
2.3.4.1 Global Ophthalmic Biologics Sale Market Share by Application (2021-2026)
2.3.4.2 Global Ophthalmic Biologics Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Ophthalmic Biologics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ophthalmic Biologics Breakdown Data by Company
3.1.1 Global Ophthalmic Biologics Annual Sales by Company (2021-2026)
3.1.2 Global Ophthalmic Biologics Sales Market Share by Company (2021-2026)
3.2 Global Ophthalmic Biologics Annual Revenue by Company (2021-2026)
3.2.1 Global Ophthalmic Biologics Revenue by Company (2021-2026)
3.2.2 Global Ophthalmic Biologics Revenue Market Share by Company (2021-2026)
3.3 Global Ophthalmic Biologics Sale Price by Company
3.4 Key Manufacturers Ophthalmic Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Biologics Product Location Distribution
3.4.2 Players Ophthalmic Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Biologics Market Size by Geographic Region (2021-2026)
4.1.1 Global Ophthalmic Biologics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ophthalmic Biologics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ophthalmic Biologics Market Size by Country/Region (2021-2026)
4.2.1 Global Ophthalmic Biologics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ophthalmic Biologics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ophthalmic Biologics Sales Growth
4.4 APAC Ophthalmic Biologics Sales Growth
4.5 Europe Ophthalmic Biologics Sales Growth
4.6 Middle East & Africa Ophthalmic Biologics Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Biologics Sales by Country
5.1.1 Americas Ophthalmic Biologics Sales by Country (2021-2026)
5.1.2 Americas Ophthalmic Biologics Revenue by Country (2021-2026)
5.2 Americas Ophthalmic Biologics Sales by Type (2021-2026)
5.3 Americas Ophthalmic Biologics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Biologics Sales by Region
6.1.1 APAC Ophthalmic Biologics Sales by Region (2021-2026)
6.1.2 APAC Ophthalmic Biologics Revenue by Region (2021-2026)
6.2 APAC Ophthalmic Biologics Sales by Type (2021-2026)
6.3 APAC Ophthalmic Biologics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Biologics by Country
7.1.1 Europe Ophthalmic Biologics Sales by Country (2021-2026)
7.1.2 Europe Ophthalmic Biologics Revenue by Country (2021-2026)
7.2 Europe Ophthalmic Biologics Sales by Type (2021-2026)
7.3 Europe Ophthalmic Biologics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Biologics by Country
8.1.1 Middle East & Africa Ophthalmic Biologics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ophthalmic Biologics Revenue by Country (2021-2026)
8.2 Middle East & Africa Ophthalmic Biologics Sales by Type (2021-2026)
8.3 Middle East & Africa Ophthalmic Biologics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Biologics
10.3 Manufacturing Process Analysis of Ophthalmic Biologics
10.4 Industry Chain Structure of Ophthalmic Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Biologics Distributors
11.3 Ophthalmic Biologics Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Biologics Market Size Forecast by Region
12.1.1 Global Ophthalmic Biologics Forecast by Region (2027-2032)
12.1.2 Global Ophthalmic Biologics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ophthalmic Biologics Forecast by Type (2027-2032)
12.7 Global Ophthalmic Biologics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Ophthalmic Biologics Product Portfolios and Specifications
13.1.3 Sanofi Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Ophthalmic Biologics Product Portfolios and Specifications
13.2.3 Novartis Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Ophthalmic Biologics Product Portfolios and Specifications
13.3.3 Bayer Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Genentech
13.4.1 Genentech Company Information
13.4.2 Genentech Ophthalmic Biologics Product Portfolios and Specifications
13.4.3 Genentech Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Genentech Main Business Overview
13.4.5 Genentech Latest Developments
13.5 Apellis Pharmaceuticals, Inc.
13.5.1 Apellis Pharmaceuticals, Inc. Company Information
13.5.2 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product Portfolios and Specifications
13.5.3 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Apellis Pharmaceuticals, Inc. Main Business Overview
13.5.5 Apellis Pharmaceuticals, Inc. Latest Developments
13.6 Coherus BioSciences Inc.
13.6.1 Coherus BioSciences Inc. Company Information
13.6.2 Coherus BioSciences Inc. Ophthalmic Biologics Product Portfolios and Specifications
13.6.3 Coherus BioSciences Inc. Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Coherus BioSciences Inc. Main Business Overview
13.6.5 Coherus BioSciences Inc. Latest Developments
13.7 Iveric Bio
13.7.1 Iveric Bio Company Information
13.7.2 Iveric Bio Ophthalmic Biologics Product Portfolios and Specifications
13.7.3 Iveric Bio Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Iveric Bio Main Business Overview
13.7.5 Iveric Bio Latest Developments
13.8 Regeneron
13.8.1 Regeneron Company Information
13.8.2 Regeneron Ophthalmic Biologics Product Portfolios and Specifications
13.8.3 Regeneron Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Regeneron Main Business Overview
13.8.5 Regeneron Latest Developments
13.9 Qilu Pharmaceutical Co.,Ltd.
13.9.1 Qilu Pharmaceutical Co.,Ltd. Company Information
13.9.2 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product Portfolios and Specifications
13.9.3 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Qilu Pharmaceutical Co.,Ltd. Main Business Overview
13.9.5 Qilu Pharmaceutical Co.,Ltd. Latest Developments
13.10 Chengdu Kanghong Pharmaceutical Group
13.10.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.10.2 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product Portfolios and Specifications
13.10.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.10.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Biologics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ophthalmic Biologics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ophthalmic Biologics by Country/Region, 2021, 2025 & 2032
2.2 Ophthalmic Biologics Segment by Type
2.2.1 Ranibizumab
2.2.2 Bevacizumab
2.2.3 Aflibercept
2.2.4 Brolucizumab
2.2.5 Faricimab
2.2.6 Others
2.2.7 Ophthalmic Biologics Sales by Type
2.2.7.1 Global Ophthalmic Biologics Sales Market Share by Type (2021-2026)
2.2.7.2 Global Ophthalmic Biologics Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Ophthalmic Biologics Sale Price by Type (2021-2026)
2.3 Ophthalmic Biologics Segment by Application
2.3.1 Age-related Macular Degeneration Treatment
2.3.2 Diabetic Retinopathy Treatment
2.3.3 Inhibit Abnormal Angiogenesis
2.3.4 Ophthalmic Biologics Sales by Application
2.3.4.1 Global Ophthalmic Biologics Sale Market Share by Application (2021-2026)
2.3.4.2 Global Ophthalmic Biologics Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Ophthalmic Biologics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ophthalmic Biologics Breakdown Data by Company
3.1.1 Global Ophthalmic Biologics Annual Sales by Company (2021-2026)
3.1.2 Global Ophthalmic Biologics Sales Market Share by Company (2021-2026)
3.2 Global Ophthalmic Biologics Annual Revenue by Company (2021-2026)
3.2.1 Global Ophthalmic Biologics Revenue by Company (2021-2026)
3.2.2 Global Ophthalmic Biologics Revenue Market Share by Company (2021-2026)
3.3 Global Ophthalmic Biologics Sale Price by Company
3.4 Key Manufacturers Ophthalmic Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Biologics Product Location Distribution
3.4.2 Players Ophthalmic Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Biologics Market Size by Geographic Region (2021-2026)
4.1.1 Global Ophthalmic Biologics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ophthalmic Biologics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ophthalmic Biologics Market Size by Country/Region (2021-2026)
4.2.1 Global Ophthalmic Biologics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ophthalmic Biologics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ophthalmic Biologics Sales Growth
4.4 APAC Ophthalmic Biologics Sales Growth
4.5 Europe Ophthalmic Biologics Sales Growth
4.6 Middle East & Africa Ophthalmic Biologics Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Biologics Sales by Country
5.1.1 Americas Ophthalmic Biologics Sales by Country (2021-2026)
5.1.2 Americas Ophthalmic Biologics Revenue by Country (2021-2026)
5.2 Americas Ophthalmic Biologics Sales by Type (2021-2026)
5.3 Americas Ophthalmic Biologics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Biologics Sales by Region
6.1.1 APAC Ophthalmic Biologics Sales by Region (2021-2026)
6.1.2 APAC Ophthalmic Biologics Revenue by Region (2021-2026)
6.2 APAC Ophthalmic Biologics Sales by Type (2021-2026)
6.3 APAC Ophthalmic Biologics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Biologics by Country
7.1.1 Europe Ophthalmic Biologics Sales by Country (2021-2026)
7.1.2 Europe Ophthalmic Biologics Revenue by Country (2021-2026)
7.2 Europe Ophthalmic Biologics Sales by Type (2021-2026)
7.3 Europe Ophthalmic Biologics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Biologics by Country
8.1.1 Middle East & Africa Ophthalmic Biologics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ophthalmic Biologics Revenue by Country (2021-2026)
8.2 Middle East & Africa Ophthalmic Biologics Sales by Type (2021-2026)
8.3 Middle East & Africa Ophthalmic Biologics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Biologics
10.3 Manufacturing Process Analysis of Ophthalmic Biologics
10.4 Industry Chain Structure of Ophthalmic Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Biologics Distributors
11.3 Ophthalmic Biologics Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Biologics Market Size Forecast by Region
12.1.1 Global Ophthalmic Biologics Forecast by Region (2027-2032)
12.1.2 Global Ophthalmic Biologics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ophthalmic Biologics Forecast by Type (2027-2032)
12.7 Global Ophthalmic Biologics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Ophthalmic Biologics Product Portfolios and Specifications
13.1.3 Sanofi Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Ophthalmic Biologics Product Portfolios and Specifications
13.2.3 Novartis Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Ophthalmic Biologics Product Portfolios and Specifications
13.3.3 Bayer Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Genentech
13.4.1 Genentech Company Information
13.4.2 Genentech Ophthalmic Biologics Product Portfolios and Specifications
13.4.3 Genentech Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Genentech Main Business Overview
13.4.5 Genentech Latest Developments
13.5 Apellis Pharmaceuticals, Inc.
13.5.1 Apellis Pharmaceuticals, Inc. Company Information
13.5.2 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product Portfolios and Specifications
13.5.3 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Apellis Pharmaceuticals, Inc. Main Business Overview
13.5.5 Apellis Pharmaceuticals, Inc. Latest Developments
13.6 Coherus BioSciences Inc.
13.6.1 Coherus BioSciences Inc. Company Information
13.6.2 Coherus BioSciences Inc. Ophthalmic Biologics Product Portfolios and Specifications
13.6.3 Coherus BioSciences Inc. Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Coherus BioSciences Inc. Main Business Overview
13.6.5 Coherus BioSciences Inc. Latest Developments
13.7 Iveric Bio
13.7.1 Iveric Bio Company Information
13.7.2 Iveric Bio Ophthalmic Biologics Product Portfolios and Specifications
13.7.3 Iveric Bio Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Iveric Bio Main Business Overview
13.7.5 Iveric Bio Latest Developments
13.8 Regeneron
13.8.1 Regeneron Company Information
13.8.2 Regeneron Ophthalmic Biologics Product Portfolios and Specifications
13.8.3 Regeneron Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Regeneron Main Business Overview
13.8.5 Regeneron Latest Developments
13.9 Qilu Pharmaceutical Co.,Ltd.
13.9.1 Qilu Pharmaceutical Co.,Ltd. Company Information
13.9.2 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product Portfolios and Specifications
13.9.3 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Qilu Pharmaceutical Co.,Ltd. Main Business Overview
13.9.5 Qilu Pharmaceutical Co.,Ltd. Latest Developments
13.10 Chengdu Kanghong Pharmaceutical Group
13.10.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.10.2 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product Portfolios and Specifications
13.10.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.10.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ophthalmic Biologics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ophthalmic Biologics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Ranibizumab
Table 4. Major Players of Bevacizumab
Table 5. Major Players of Aflibercept
Table 6. Major Players of Brolucizumab
Table 7. Major Players of Faricimab
Table 8. Major Players of Others
Table 9. Global Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 10. Global Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Table 11. Global Ophthalmic Biologics Revenue by Type (2021-2026) & ($ million)
Table 12. Global Ophthalmic Biologics Revenue Market Share by Type (2021-2026)
Table 13. Global Ophthalmic Biologics Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Ophthalmic Biologics Sale by Application (2021-2026) & (K Units)
Table 15. Global Ophthalmic Biologics Sale Market Share by Application (2021-2026)
Table 16. Global Ophthalmic Biologics Revenue by Application (2021-2026) & ($ million)
Table 17. Global Ophthalmic Biologics Revenue Market Share by Application (2021-2026)
Table 18. Global Ophthalmic Biologics Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Ophthalmic Biologics Sales by Company (2021-2026) & (K Units)
Table 20. Global Ophthalmic Biologics Sales Market Share by Company (2021-2026)
Table 21. Global Ophthalmic Biologics Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Ophthalmic Biologics Revenue Market Share by Company (2021-2026)
Table 23. Global Ophthalmic Biologics Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Ophthalmic Biologics Producing Area Distribution and Sales Area
Table 25. Players Ophthalmic Biologics Products Offered
Table 26. Ophthalmic Biologics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Ophthalmic Biologics Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Ophthalmic Biologics Sales Market Share Geographic Region (2021-2026)
Table 31. Global Ophthalmic Biologics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Ophthalmic Biologics Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Ophthalmic Biologics Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Ophthalmic Biologics Sales Market Share by Country/Region (2021-2026)
Table 35. Global Ophthalmic Biologics Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Ophthalmic Biologics Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Ophthalmic Biologics Sales by Country (2021-2026) & (K Units)
Table 38. Americas Ophthalmic Biologics Sales Market Share by Country (2021-2026)
Table 39. Americas Ophthalmic Biologics Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 41. Americas Ophthalmic Biologics Sales by Application (2021-2026) & (K Units)
Table 42. APAC Ophthalmic Biologics Sales by Region (2021-2026) & (K Units)
Table 43. APAC Ophthalmic Biologics Sales Market Share by Region (2021-2026)
Table 44. APAC Ophthalmic Biologics Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 46. APAC Ophthalmic Biologics Sales by Application (2021-2026) & (K Units)
Table 47. Europe Ophthalmic Biologics Sales by Country (2021-2026) & (K Units)
Table 48. Europe Ophthalmic Biologics Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 50. Europe Ophthalmic Biologics Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Ophthalmic Biologics Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Ophthalmic Biologics Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Ophthalmic Biologics Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Ophthalmic Biologics
Table 56. Key Market Challenges & Risks of Ophthalmic Biologics
Table 57. Key Industry Trends of Ophthalmic Biologics
Table 58. Ophthalmic Biologics Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Ophthalmic Biologics Distributors List
Table 61. Ophthalmic Biologics Customer List
Table 62. Global Ophthalmic Biologics Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Ophthalmic Biologics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Ophthalmic Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Ophthalmic Biologics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Ophthalmic Biologics Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Ophthalmic Biologics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Ophthalmic Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Ophthalmic Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Ophthalmic Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Ophthalmic Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Ophthalmic Biologics Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Ophthalmic Biologics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Ophthalmic Biologics Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Ophthalmic Biologics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Sanofi Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 77. Sanofi Ophthalmic Biologics Product Portfolios and Specifications
Table 78. Sanofi Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Sanofi Main Business
Table 80. Sanofi Latest Developments
Table 81. Novartis Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 82. Novartis Ophthalmic Biologics Product Portfolios and Specifications
Table 83. Novartis Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Novartis Main Business
Table 85. Novartis Latest Developments
Table 86. Bayer Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer Ophthalmic Biologics Product Portfolios and Specifications
Table 88. Bayer Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Genentech Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 92. Genentech Ophthalmic Biologics Product Portfolios and Specifications
Table 93. Genentech Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Genentech Main Business
Table 95. Genentech Latest Developments
Table 96. Apellis Pharmaceuticals, Inc. Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 97. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product Portfolios and Specifications
Table 98. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Apellis Pharmaceuticals, Inc. Main Business
Table 100. Apellis Pharmaceuticals, Inc. Latest Developments
Table 101. Coherus BioSciences Inc. Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 102. Coherus BioSciences Inc. Ophthalmic Biologics Product Portfolios and Specifications
Table 103. Coherus BioSciences Inc. Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Coherus BioSciences Inc. Main Business
Table 105. Coherus BioSciences Inc. Latest Developments
Table 106. Iveric Bio Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 107. Iveric Bio Ophthalmic Biologics Product Portfolios and Specifications
Table 108. Iveric Bio Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Iveric Bio Main Business
Table 110. Iveric Bio Latest Developments
Table 111. Regeneron Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 112. Regeneron Ophthalmic Biologics Product Portfolios and Specifications
Table 113. Regeneron Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Regeneron Main Business
Table 115. Regeneron Latest Developments
Table 116. Qilu Pharmaceutical Co.,Ltd. Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 117. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product Portfolios and Specifications
Table 118. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Qilu Pharmaceutical Co.,Ltd. Main Business
Table 120. Qilu Pharmaceutical Co.,Ltd. Latest Developments
Table 121. Chengdu Kanghong Pharmaceutical Group Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 122. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product Portfolios and Specifications
Table 123. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Chengdu Kanghong Pharmaceutical Group Main Business
Table 125. Chengdu Kanghong Pharmaceutical Group Latest Developments
Table 1. Ophthalmic Biologics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ophthalmic Biologics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Ranibizumab
Table 4. Major Players of Bevacizumab
Table 5. Major Players of Aflibercept
Table 6. Major Players of Brolucizumab
Table 7. Major Players of Faricimab
Table 8. Major Players of Others
Table 9. Global Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 10. Global Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Table 11. Global Ophthalmic Biologics Revenue by Type (2021-2026) & ($ million)
Table 12. Global Ophthalmic Biologics Revenue Market Share by Type (2021-2026)
Table 13. Global Ophthalmic Biologics Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Ophthalmic Biologics Sale by Application (2021-2026) & (K Units)
Table 15. Global Ophthalmic Biologics Sale Market Share by Application (2021-2026)
Table 16. Global Ophthalmic Biologics Revenue by Application (2021-2026) & ($ million)
Table 17. Global Ophthalmic Biologics Revenue Market Share by Application (2021-2026)
Table 18. Global Ophthalmic Biologics Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Ophthalmic Biologics Sales by Company (2021-2026) & (K Units)
Table 20. Global Ophthalmic Biologics Sales Market Share by Company (2021-2026)
Table 21. Global Ophthalmic Biologics Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Ophthalmic Biologics Revenue Market Share by Company (2021-2026)
Table 23. Global Ophthalmic Biologics Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Ophthalmic Biologics Producing Area Distribution and Sales Area
Table 25. Players Ophthalmic Biologics Products Offered
Table 26. Ophthalmic Biologics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Ophthalmic Biologics Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Ophthalmic Biologics Sales Market Share Geographic Region (2021-2026)
Table 31. Global Ophthalmic Biologics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Ophthalmic Biologics Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Ophthalmic Biologics Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Ophthalmic Biologics Sales Market Share by Country/Region (2021-2026)
Table 35. Global Ophthalmic Biologics Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Ophthalmic Biologics Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Ophthalmic Biologics Sales by Country (2021-2026) & (K Units)
Table 38. Americas Ophthalmic Biologics Sales Market Share by Country (2021-2026)
Table 39. Americas Ophthalmic Biologics Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 41. Americas Ophthalmic Biologics Sales by Application (2021-2026) & (K Units)
Table 42. APAC Ophthalmic Biologics Sales by Region (2021-2026) & (K Units)
Table 43. APAC Ophthalmic Biologics Sales Market Share by Region (2021-2026)
Table 44. APAC Ophthalmic Biologics Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 46. APAC Ophthalmic Biologics Sales by Application (2021-2026) & (K Units)
Table 47. Europe Ophthalmic Biologics Sales by Country (2021-2026) & (K Units)
Table 48. Europe Ophthalmic Biologics Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 50. Europe Ophthalmic Biologics Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Ophthalmic Biologics Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Ophthalmic Biologics Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Ophthalmic Biologics Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Ophthalmic Biologics Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Ophthalmic Biologics
Table 56. Key Market Challenges & Risks of Ophthalmic Biologics
Table 57. Key Industry Trends of Ophthalmic Biologics
Table 58. Ophthalmic Biologics Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Ophthalmic Biologics Distributors List
Table 61. Ophthalmic Biologics Customer List
Table 62. Global Ophthalmic Biologics Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Ophthalmic Biologics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Ophthalmic Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Ophthalmic Biologics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Ophthalmic Biologics Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Ophthalmic Biologics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Ophthalmic Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Ophthalmic Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Ophthalmic Biologics Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Ophthalmic Biologics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Ophthalmic Biologics Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Ophthalmic Biologics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Ophthalmic Biologics Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Ophthalmic Biologics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Sanofi Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 77. Sanofi Ophthalmic Biologics Product Portfolios and Specifications
Table 78. Sanofi Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Sanofi Main Business
Table 80. Sanofi Latest Developments
Table 81. Novartis Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 82. Novartis Ophthalmic Biologics Product Portfolios and Specifications
Table 83. Novartis Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Novartis Main Business
Table 85. Novartis Latest Developments
Table 86. Bayer Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer Ophthalmic Biologics Product Portfolios and Specifications
Table 88. Bayer Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Genentech Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 92. Genentech Ophthalmic Biologics Product Portfolios and Specifications
Table 93. Genentech Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Genentech Main Business
Table 95. Genentech Latest Developments
Table 96. Apellis Pharmaceuticals, Inc. Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 97. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product Portfolios and Specifications
Table 98. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Apellis Pharmaceuticals, Inc. Main Business
Table 100. Apellis Pharmaceuticals, Inc. Latest Developments
Table 101. Coherus BioSciences Inc. Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 102. Coherus BioSciences Inc. Ophthalmic Biologics Product Portfolios and Specifications
Table 103. Coherus BioSciences Inc. Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Coherus BioSciences Inc. Main Business
Table 105. Coherus BioSciences Inc. Latest Developments
Table 106. Iveric Bio Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 107. Iveric Bio Ophthalmic Biologics Product Portfolios and Specifications
Table 108. Iveric Bio Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Iveric Bio Main Business
Table 110. Iveric Bio Latest Developments
Table 111. Regeneron Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 112. Regeneron Ophthalmic Biologics Product Portfolios and Specifications
Table 113. Regeneron Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Regeneron Main Business
Table 115. Regeneron Latest Developments
Table 116. Qilu Pharmaceutical Co.,Ltd. Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 117. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product Portfolios and Specifications
Table 118. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Qilu Pharmaceutical Co.,Ltd. Main Business
Table 120. Qilu Pharmaceutical Co.,Ltd. Latest Developments
Table 121. Chengdu Kanghong Pharmaceutical Group Basic Information, Ophthalmic Biologics Manufacturing Base, Sales Area and Its Competitors
Table 122. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product Portfolios and Specifications
Table 123. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Chengdu Kanghong Pharmaceutical Group Main Business
Table 125. Chengdu Kanghong Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ophthalmic Biologics
Figure 2. Ophthalmic Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Biologics Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Ophthalmic Biologics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ophthalmic Biologics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ophthalmic Biologics Sales Market Share by Country/Region (2025)
Figure 10. Ophthalmic Biologics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Ranibizumab
Figure 12. Product Picture of Bevacizumab
Figure 13. Product Picture of Aflibercept
Figure 14. Product Picture of Brolucizumab
Figure 15. Product Picture of Faricimab
Figure 16. Product Picture of Others
Figure 17. Global Ophthalmic Biologics Sales Market Share by Type in 2026
Figure 18. Global Ophthalmic Biologics Revenue Market Share by Type (2021-2026)
Figure 19. Ophthalmic Biologics Consumed in Age-related Macular Degeneration Treatment
Figure 20. Global Ophthalmic Biologics Market: Age-related Macular Degeneration Treatment (2021-2026) & (K Units)
Figure 21. Ophthalmic Biologics Consumed in Diabetic Retinopathy Treatment
Figure 22. Global Ophthalmic Biologics Market: Diabetic Retinopathy Treatment (2021-2026) & (K Units)
Figure 23. Ophthalmic Biologics Consumed in Inhibit Abnormal Angiogenesis
Figure 24. Global Ophthalmic Biologics Market: Inhibit Abnormal Angiogenesis (2021-2026) & (K Units)
Figure 25. Global Ophthalmic Biologics Sale Market Share by Application (2025)
Figure 26. Global Ophthalmic Biologics Revenue Market Share by Application in 2026
Figure 27. Ophthalmic Biologics Sales by Company in 2026 (K Units)
Figure 28. Global Ophthalmic Biologics Sales Market Share by Company in 2026
Figure 29. Ophthalmic Biologics Revenue by Company in 2026 ($ millions)
Figure 30. Global Ophthalmic Biologics Revenue Market Share by Company in 2026
Figure 31. Global Ophthalmic Biologics Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Ophthalmic Biologics Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Ophthalmic Biologics Sales 2021-2026 (K Units)
Figure 34. Americas Ophthalmic Biologics Revenue 2021-2026 ($ millions)
Figure 35. APAC Ophthalmic Biologics Sales 2021-2026 (K Units)
Figure 36. APAC Ophthalmic Biologics Revenue 2021-2026 ($ millions)
Figure 37. Europe Ophthalmic Biologics Sales 2021-2026 (K Units)
Figure 38. Europe Ophthalmic Biologics Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Ophthalmic Biologics Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Ophthalmic Biologics Revenue 2021-2026 ($ millions)
Figure 41. Americas Ophthalmic Biologics Sales Market Share by Country in 2026
Figure 42. Americas Ophthalmic Biologics Revenue Market Share by Country (2021-2026)
Figure 43. Americas Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Figure 44. Americas Ophthalmic Biologics Sales Market Share by Application (2021-2026)
Figure 45. United States Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Ophthalmic Biologics Sales Market Share by Region in 2026
Figure 50. APAC Ophthalmic Biologics Revenue Market Share by Region (2021-2026)
Figure 51. APAC Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Figure 52. APAC Ophthalmic Biologics Sales Market Share by Application (2021-2026)
Figure 53. China Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 57. India Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Ophthalmic Biologics Sales Market Share by Country in 2026
Figure 61. Europe Ophthalmic Biologics Revenue Market Share by Country (2021-2026)
Figure 62. Europe Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Figure 63. Europe Ophthalmic Biologics Sales Market Share by Application (2021-2026)
Figure 64. Germany Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 65. France Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Ophthalmic Biologics Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Ophthalmic Biologics Sales Market Share by Application (2021-2026)
Figure 72. Egypt Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Ophthalmic Biologics in 2026
Figure 78. Manufacturing Process Analysis of Ophthalmic Biologics
Figure 79. Industry Chain Structure of Ophthalmic Biologics
Figure 80. Channels of Distribution
Figure 81. Global Ophthalmic Biologics Sales Market Forecast by Region (2027-2032)
Figure 82. Global Ophthalmic Biologics Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Ophthalmic Biologics Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Ophthalmic Biologics Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Ophthalmic Biologics Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Ophthalmic Biologics Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Ophthalmic Biologics
Figure 2. Ophthalmic Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Biologics Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Ophthalmic Biologics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ophthalmic Biologics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ophthalmic Biologics Sales Market Share by Country/Region (2025)
Figure 10. Ophthalmic Biologics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Ranibizumab
Figure 12. Product Picture of Bevacizumab
Figure 13. Product Picture of Aflibercept
Figure 14. Product Picture of Brolucizumab
Figure 15. Product Picture of Faricimab
Figure 16. Product Picture of Others
Figure 17. Global Ophthalmic Biologics Sales Market Share by Type in 2026
Figure 18. Global Ophthalmic Biologics Revenue Market Share by Type (2021-2026)
Figure 19. Ophthalmic Biologics Consumed in Age-related Macular Degeneration Treatment
Figure 20. Global Ophthalmic Biologics Market: Age-related Macular Degeneration Treatment (2021-2026) & (K Units)
Figure 21. Ophthalmic Biologics Consumed in Diabetic Retinopathy Treatment
Figure 22. Global Ophthalmic Biologics Market: Diabetic Retinopathy Treatment (2021-2026) & (K Units)
Figure 23. Ophthalmic Biologics Consumed in Inhibit Abnormal Angiogenesis
Figure 24. Global Ophthalmic Biologics Market: Inhibit Abnormal Angiogenesis (2021-2026) & (K Units)
Figure 25. Global Ophthalmic Biologics Sale Market Share by Application (2025)
Figure 26. Global Ophthalmic Biologics Revenue Market Share by Application in 2026
Figure 27. Ophthalmic Biologics Sales by Company in 2026 (K Units)
Figure 28. Global Ophthalmic Biologics Sales Market Share by Company in 2026
Figure 29. Ophthalmic Biologics Revenue by Company in 2026 ($ millions)
Figure 30. Global Ophthalmic Biologics Revenue Market Share by Company in 2026
Figure 31. Global Ophthalmic Biologics Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Ophthalmic Biologics Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Ophthalmic Biologics Sales 2021-2026 (K Units)
Figure 34. Americas Ophthalmic Biologics Revenue 2021-2026 ($ millions)
Figure 35. APAC Ophthalmic Biologics Sales 2021-2026 (K Units)
Figure 36. APAC Ophthalmic Biologics Revenue 2021-2026 ($ millions)
Figure 37. Europe Ophthalmic Biologics Sales 2021-2026 (K Units)
Figure 38. Europe Ophthalmic Biologics Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Ophthalmic Biologics Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Ophthalmic Biologics Revenue 2021-2026 ($ millions)
Figure 41. Americas Ophthalmic Biologics Sales Market Share by Country in 2026
Figure 42. Americas Ophthalmic Biologics Revenue Market Share by Country (2021-2026)
Figure 43. Americas Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Figure 44. Americas Ophthalmic Biologics Sales Market Share by Application (2021-2026)
Figure 45. United States Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Ophthalmic Biologics Sales Market Share by Region in 2026
Figure 50. APAC Ophthalmic Biologics Revenue Market Share by Region (2021-2026)
Figure 51. APAC Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Figure 52. APAC Ophthalmic Biologics Sales Market Share by Application (2021-2026)
Figure 53. China Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 57. India Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Ophthalmic Biologics Sales Market Share by Country in 2026
Figure 61. Europe Ophthalmic Biologics Revenue Market Share by Country (2021-2026)
Figure 62. Europe Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Figure 63. Europe Ophthalmic Biologics Sales Market Share by Application (2021-2026)
Figure 64. Germany Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 65. France Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Ophthalmic Biologics Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Ophthalmic Biologics Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Ophthalmic Biologics Sales Market Share by Application (2021-2026)
Figure 72. Egypt Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Ophthalmic Biologics Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Ophthalmic Biologics in 2026
Figure 78. Manufacturing Process Analysis of Ophthalmic Biologics
Figure 79. Industry Chain Structure of Ophthalmic Biologics
Figure 80. Channels of Distribution
Figure 81. Global Ophthalmic Biologics Sales Market Forecast by Region (2027-2032)
Figure 82. Global Ophthalmic Biologics Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Ophthalmic Biologics Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Ophthalmic Biologics Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Ophthalmic Biologics Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Ophthalmic Biologics Revenue Market Share Forecast by Application (2027-2032)
